A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.
- DOI
- 10.1007/s11523-024-01051-2
- Published
- 2024 May
- Container
- Targeted oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11523-024-01051-2,
title = {A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.},
author = {Evans L and Walker R and MacDiarmid J and Brahmbhatt H and Anazodo A and McCowage G and Gifford AJ and Kavallaris M and Trahair T and Ziegler DS},
year = {2024},
journal = {Targeted oncology},
doi = {10.1007/s11523-024-01051-2},
url = {https://doi.org/10.1007/s11523-024-01051-2}
}RIS
TY - JOUR TI - A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor. AU - Evans L AU - Walker R AU - MacDiarmid J AU - Brahmbhatt H AU - Anazodo A AU - McCowage G AU - Gifford AJ AU - Kavallaris M AU - Trahair T AU - Ziegler DS PY - 2024 JO - Targeted oncology DO - 10.1007/s11523-024-01051-2 UR - https://doi.org/10.1007/s11523-024-01051-2 ER -
APA
L, E., R, W., J, M., H, B., A, A., G, M., AJ, G., M, K., T, T., & DS, Z. (2024). A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.. Targeted oncology. https://doi.org/10.1007/s11523-024-01051-2
Source records
- pubmed · retrieved 2026-09-26T12:51:26.887Z